Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis? — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Is Negativity of Autoantibodies a Marker of Severity in Auto-immune Hepatitis? — Stella

Home/Auto-immune Hepatitis/

View on ClinicalTrials.gov

Recruiting

Back to Auto-immune Hepatitis trials

Trial locations(2 sites)

France

Hospital of Saint-Antoine, Paris, France

CHU de Pointe-à Pitre, Pointe à Pitre, Guadeloupe

Key details

Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Enrollment target

~100 participants

Started

July 2022

Primary completion

December 2026

Age range

18 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.